Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 8,857 | 6,560 | 10,876 | 207,834 | 0 |
| Gross Profit | 8,857 | 6,560 | 10,876 | 207,834 | N/A |
| Operating Expenses | 131,148 | 115,104 | 105,446 | 99,382 | 88,806 |
| Operating Income | -122,291 | -108,544 | -94,570 | 108,452 | -88,806 |
| Other Income | 9,839 | 10,005 | 11,297 | 10,792 | 11,315 |
| Pre-tax Income | -112,452 | -98,539 | -83,273 | 119,244 | -77,491 |
| Net Income Continuous | -112,452 | -98,539 | -83,273 | 119,244 | -77,491 |
| Net Income | $-112,452 | $-98,539 | $-83,273 | $119,244 | $-77,491 |
| EPS Basic Total Ops | -1.22 | -1.11 | -0.93 | 1.35 | -0.88 |
| EPS Basic Continuous Ops | -1.22 | -1.11 | -0.94 | 1.35 | -0.88 |
| EPS Diluted Total Ops | -1.22 | -1.11 | -0.91 | 1.33 | -0.88 |
| EPS Diluted Continuous Ops | -1.22 | -1.11 | -0.92 | 1.33 | -0.88 |
| EPS Diluted Before Non-Recurring Items | -1.22 | -1.11 | -0.94 | 1.33 | -0.88 |
| EBITDA(a) | $-122,188 | $-108,612 | $-94,897 | $107,500 | $-90,265 |